Latest Breaking News On - Seamus fernandez guggenheim - Page 12 : comparemela.com

Operator Good day, and welcome to the Bristol-Myers Squibb 2021 first-quarter results conference call. Today s conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, vice president of investor relations. Please go ahead, sir. Vice President, Investor Relations Thanks, Keith. And good morning, everyone. Thanks for joining us today for our first-quarter 2021 earnings call. Joining me this morning with prepared remarks are Giovanni Caforio, our board chair and chief executive officer; and David Elkins, our chief financial officer. Also participating in today s call for Q&A are Chris Boerner, our chief commercialization officer; and Samit Hirawat, our chief medical officer and head of global drug development. As you will see, we ve posted slides to bms.com that you can use to follow along with for today s remarks. But before we get started, let me read our forward-looking statements. During this call, we ll make statements about the co

Seamus fernandez guggenheimTim andersonDavid elkinsSeamus fernandezChris boernerTerence flynn goldman sachsBristol myers squibbChris schottTerence flynnSamit hirawatGiovanni caforioTim anderson wolfe research analystHead of global drug developmentGoldman sachsWolfe researchStim power